Sana Biotechnology (SANA) Other Operating Expenses (2020 - 2026)

Sana Biotechnology's Other Operating Expenses history runs 7 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 330.91% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $170.4 million (up 284.92% YoY), while the FY2025 annual figure was $74.0 million, up 127.97% from the prior year.
• Other Operating Expenses came in at $8.4 million for Q1 2026 at Sana Biotechnology, down from $196.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $196.7 million in Q4 2025 to a low of -$249.4 million in Q4 2022.
• A 5-year average of -$18.4 million and a median of -$6.1 million in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses plunged 57315.0% in 2024 and jumped 1286.81% in 2025, its largest moves.
• Sana Biotechnology's Other Operating Expenses stood at -$249.4 million in 2022, then soared by 125.19% to $62.8 million in 2023, then plunged by 126.37% to -$16.6 million in 2024, then surged by 1286.81% to $196.7 million in 2025, then slumped by 95.71% to $8.4 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $8.4 million, $196.7 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison